Health> Vol.6 No.7, March 2014

Mental Health Outreach at Community Behavior Health Centers

DownloadDownload as PDF (Size:675KB)  HTML    PP. 531-540  

ABSTRACT

Background: Major Depressive Disorder (MDD) is considered to be one of the most common incapacitating psychiatric diseases. A pharmacist interacting with patients has the potential to enhance compliance, ensure proper medication use, and monitor adverse effects that will ultimately improve patients’ quality of care. Methods: The primary objectives of this study were to 1) assess individuals’ knowledge of depression before and after a 30-minute educational intervention and 2) measure satisfaction with the program. The pre- and post-test consisted of 11 identical questions that assessed individuals’ knowledge regarding depression. The survey consisted of four questions that rated program satisfaction. Results: Although 82 individuals participated in some aspect of the program, 56 individuals completed the program requirements and were included in the data analysis. Four hundred and eighty six of the total 616 (56 participants × 11 questions) pre-test questions (79%) were answered correctly at the beginning of the program. A total of 556 post-test questions (90%) were answered correctly at the conclusion of the program, with an overall increase of 70 (p ≤ 0.001) more correct answers. Correct responses to five questions were statistically significant for improved post-test scores: Over-the-counter or herbal medications will interfere with your medication (p = 0.01); certain foods can interfere with medications that affect mood (p = 0.01); it is safe to use multiple pharmacies to get your medications (p = 0.001); the main chemical of the brain that is not balanced in depression (p ≤ 0.001); and the most common type of medication for depression (p ≤ 0.001). Overall, 95% of participants would recommend the program to a friend or family member. Conclusion: The data from this program supports that pharmacists can have a positive impact in the mental health field and satisfaction with such services in the community.

Cite this paper

Sobota, K. , Blackwell, J. , Dye, B. , Kapoor, K. , Roediger, E. and Sobota, M. (2014) Mental Health Outreach at Community Behavior Health Centers. Health, 6, 531-540. doi: 10.4236/health.2014.67072.

References

[1] Kupfer, D.J., Ellen, F. and Phillips, M. (2012) Major Depressive Disorder: New Clinical, Neurobiological, and Treatment Perspectives. Lancet, 379, 1045-1055.
http://dx.doi.org/10.1016/S0140-6736(11)60602-8
[2] Klein, D.N., Glenn, C.R., Kosty, D.B., Seeley, J.R., Rohde, P. and Lewinsohn, P.M. (2013) Predictors of First Lifetime Onset of Major Depressive Disorder in Young Adulthood. Journal of Abnormal Psychology, 122, 1-6.
http://dx.doi.org/10.1037/a0029567
[3] American Psychiatric Association. (2013) Major Depressive Disorder and the “Bereavement Exclusion”. American Psychiatric Press, Inc., Washington DC.
http://www.dsm5.org
[4] Wang, P.S., Berglund, P. and Kessler, R.C. (2000) Recent Care of Common Mental Disorders in the United States Prevalence and Conformance with Evidence-Based Recommendations. Journal of General Internal Medicine, 15, 284-292.
http://dx.doi.org/10.1046/j.1525-1497.2000.9908044.x
[5] Blumenthal, J.A., Babyak, M.A., Doraiswamy, P.M., Watkins, L., Hoffman, B.M., Barbour, K.A., et al. (2007) Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder. Psychosomatic Medicine, 69, 587-596.
http://dx.doi.org/10.1097/PSY.0b013e318148c19a
[6] National Institute of Mental Health (2013) Depression. Bethesda.
http://www.nimh.nih.gov/health/topics/depression/index.shtml#part4
http://www.nimh.nih.gov/statistics/1mdd_adult.shtml
[7] Toukhsati, S. and Hare, D. (2013) Detecting and Managing Depression in Patients with Cardiac Disease. Cardiology Today, 3, 27-30.
[8] Depressive Disorders. The Merck Manuals: The Merck Manual for Healthcare Professionals.
http://www.merckmanuals.com/professional/psychiatric_disorders/mood_disorders/depressive_disorders.html#top
[9] Starks, J.M., Poulin, C.C. and Kisley, S.R. (2005) Unmet Need for the Treatment of Depression in Atlantic Canada. Canadian Journal of Psychiatry, 50, 580-590.
[10] Substance Abuse and Mental Health Services Administration (2012) Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings. NSDUH Series H-45, Substance Abuse and Mental Health Services Administration, Rockville.
[11] United States Department of Labor: Bureau of Labor Statistics.
www.bls.gov/ncs/ebs/
[12] Finley, P.R., Crismon, M.L. and Rush, A.J. (2003) Evaluating the Impact of Pharmacists in Mental Health: A Systematic Review. Pharmacotherapy, 23, 1634-1644.
[13] Capoccia, K.L., Boudreau, D.M., Blough, D.K., Ellsworth, A.J., Clark, D.R., Stevens, N.G., et al. (2004) Randomized Trial of Pharmacist Interventions to Improve Depression Care and Outcomes in Primary Care. American Journal of Health-System Pharmacy, 61, 364-372.
[14] Crockett, J., Taylor, S., Grabham, A. and Stanford, P. (2006) Patient Outcomes Following an Intervention Involving Community Pharmacists in the Management of Depression. Australian Journal of Rural Health, 14, 263-269.
http://dx.doi.org/10.1111/j.1440-1584.2006.00827.x
[15] Gilbody, S., Whitty, P., Grimshaw, J. and Thomas, R. (2003) Educational and Organizational Interventions to Improve the Management of Depression in Primary Care. Journal of the American Medical Association, 289, 3145-3151.
http://dx.doi.org/10.1001/jama.289.23.3145
[16] Strine, T.W., Mokdad, A.H., Balluz, L.S., et al. (2008) Depression and Anxiety in the United States: Findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatric Services, 59, 1383-1390.
http://dx.doi.org/10.1176/appi.ps.59.12.1383
[17] Chapman, D.P., Perry, G.S. and Strine, T.W. (2005) The Vital Link between Chronic Disease and Depressive Disorders. Preventing Chronic Disease, 2, A14.

comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.